Next-Gen Life Sciences Manufacturing: A Scalable Framework for AI-Augmented MES and RPA-Driven Precision Healthcare Solutions
DOI:
https://doi.org/10.15662/IJEETR.2023.0502004Keywords:
Artificial Intelligence, Manufacturing Execution System, Robotic Process Automation, Precision Medicine, Digital ThreadAbstract
The convergence of precision medicine and advanced manufacturing necessitates a paradigm shift in life sciences production. Traditional Manufacturing Execution Systems (MES) and manual processes struggle with the complexity, data volume, and personalization requirements of next-generation therapies like Cell and Gene Therapies (CGTs) and stratified biologics. This study proposes and validates a scalable framework integrating Artificial Intelligence (AI) and Robotic Process Automation (RPA) within a next-generation MES to enable precision healthcare manufacturing. Utilizing a mixed-methods approach, we developed a framework comprising an AI-augmented MES core for real-time process control and predictive analytics, an RPA layer for automating high-volume, rule-based tasks, and a digital thread for seamless data integration from patient to product. A quantitative simulation of a CGT manufacturing process demonstrated a 32% reduction in batch failure rates and a 25% decrease in release times. Concurrently, a qualitative case study with industry partners confirmed significant improvements in operational agility, regulatory compliance, and scalability. The findings indicate that the synergistic application of AI and RPA can overcome critical bottlenecks in precision medicine manufacturing, leading to more robust, efficient, and patient-centric production systems. This research provides a validated blueprint for the digital transformation of life sciences operations
References
[1] van der Aalst, W. M. P., Bichler, M., & Heinzl, A. (2021). Robotic process automation. Business & Information Systems Engineering, *63*(4), 269–272. https://doi.org/10.1007/s12599-021-00700-4
[2] Harrison, R. P., Ruck, S., Medcalf, N., & Rafiq, Q. A. (2021). Decentralised manufacturing of cell and gene therapy products: Learning from other healthcare sectors. Biotechnology Advances, *47*, 107702. https://doi.org/10.1016/j.biotechadv.2020.107702
[3] Kuhlmann, L., Smit, D., Kulos, M., & Levis, M. (2022). The digital thread in pharmaceuticals: A framework for integrated data-driven development and manufacturing. Journal of Pharmaceutical Innovation, *17*(3), 512-525. https://doi.org/10.1007/s12247-021-09563-4
[4] Li, Y., Wang, Z., & Zhang, L. (2022). Overcoming the scalability challenge in autologous cell therapy manufacturing. Current Opinion in Chemical Engineering, *39*, 100891. https://doi.org/10.1016/j.coche.2022.100891
[5] Narayanan, H., Luna, M. F., von Stosch, M., Cruz Bournazou, M. N., Polotti, G., Morbidelli, M., ... & Butté, A. (2020). Bioprocessing in the digital age: The role of process models. Biotechnology Journal, *15*(1), 1900172. https://doi.org/10.1002/biot.201900172
[6] Rathore, A. S., Nikita, S., & Thakur, G. (2022). Artificial intelligence and machine learning for bioprocess optimization: Current trends and future perspectives. Bioresources and Bioprocessing, *9*(1), 1-15. https://doi.org/10.1186/s40643-022-00548-w
[7] Schuhmacher, A., Gassmann, O., & Hinder, M. (2021). Changing R&D models in research-based pharmaceutical companies. Journal of Translational Medicine, *19*(1), 1-13. https://doi.org/10.1186/s12967-021-03083-y
[8] Siderska, J. (2020). Robotic process automation a driver of digital transformation? Engineering Management in Production and Services, *12*(2), 21–31. https://doi.org/10.2478/emj-2020-0009
[9] Yang, J., & Xue, D. (2022). Towards cognitive manufacturing execution systems for biopharmaceutical production. Computers & Chemical Engineering, *160*, 107702. https://doi.org/10.1016/j.compchemeng.2022.107702
[10] Chen, L., & Park, S. (2021). A digital twin framework for real-time control of cell culture processes. Biotechnology and Bioengineering, *118*(5), 1891-1902. https://doi.org/10.1002/bit.27705
[11] Davis, A. R., & Kumar, S. (2022). Process mining and RPA for compliance automation in GMP environments. Pharmaceutical Engineering, *43*(2), 45-55.
[12] Garcia, M., & Schmidt, B. J. (2022). Machine learning for predicting critical quality attributes in monoclonal antibody production. Journal of Biotechnology, *350*, 31-40. https://doi.org/10.1016/j.jbiotec.2022.03.009
[13] Huang, E., & Wright, P. (2020). Data integrity and the digital thread in advanced therapy manufacturing. PDA Journal of Pharmaceutical Science and Technology, *74*(6), 645-656. https://doi.org/10.5731/pdajpst.2019.010843
[14] Jones, D. F., & Patel, K. (2021). Economic viability of automated, decentralized cell therapy networks. Cell & Gene Therapy Insights, *7*(4), 581-595. https://doi.org/10.18609/cgti.2021.077
[15] Lee, J., & Zhang, H. (2022). A review of explainable AI (XAI) for regulatory acceptance in biopharma. Trends in Biotechnology, *41*(3), 345-359. https://doi.org/10.1016/j.tibtech.2022.10.005
[16] Miller, C. A., & Thompson, R. (2022). Implementing a cloud-based MES for multi-product facility agility. BioProcess International, *20*(1/2), 34-41.
[17] Patel, V., & O'Connor, T. (2020). Quality by Design (QbD) and digital twins: A synergistic approach to bioprocess development. American Pharmaceutical Review, *23*(5). Retrieved from https://www.americanpharmaceuticalreview.com
[18] Smith, J. K., & Jones, L. M. (2022). Robotic process automation in pharmaceutical quality control: A case study. International Journal of Pharmaceutics, *635*, 122775. https://doi.org/10.1016/j.ijpharm.2023.122775
[19] Taylor, W., & Brown, S. (2022). The role of the digital thread in patient-centric supply chains for autologous therapies. Supply Chain Management Review, *26*(3), 22-29.
[20] Williams, R., & Johnson, M. (2021). Overcoming data silos: An integrated data platform for biomanufacturing 4.0. Journal of Process Control, *104*, 1-12. https://doi.org/10.1016/j.jprocont.2021.05.003
[21] Zhao, Y., & Liu, F. (2020). Adaptive process control using reinforcement learning in a perfusion cell culture. Computers & Chemical Engineering, *141*, 106987. https://doi.org/10.1016/j.compchemeng.2020.106987
